2 news items
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
MBRX
9 May 24
which we expect to have in the near future. The issuance of this patent further underscores the importance and proprietary nature of the innovation
Moleculin Announces U.S. Patent Issue Notification for Annamycin Targeting Unmet Need in AML
MBRX
27 Mar 24
in this 2nd line space by a wide margin. Issuance of this patent underscores the importance and proprietary nature of the innovation that makes
- Prev
- 1
- Next